Pityriasis rubra pilaris post-infection due COVID-19: case report
Abstract
Case description: 32-month-old boy, IgG positive for SARS-CoV-2, presented to the emergency department with dermatologic lesions.
Clinical findings: Four days before admission, he presented skin eruptions with redness and pruritus on hands and feet. Generalized papular erythema was evidenced, upper extremities with diffuse erythematosquamous plaques, palmoplantar keratoderma, so he was evaluated by a dermatologist who diagnosed pityriasis rubra pilaris.
Treatment and outcome: rehydrating cream, cetirizine 0.5 mg/kg/day every two days, and prednisolone 2 mg/kg/day in the morning. He was discharged after 14 days, the patient presented clinical improvement, but the erythematous lesion persisted on the trunk and extremities. In the evaluation, after three months, the patient did not show the described lesions, evidencing an improvement and clinical resolution of the dermatological problems.
Clinical relevance: We report a patient with pityriasis rubra piloris associated with a post-infection by SARS-CoV-2 that had not been described before.
Authors
Downloads
Keywords
- SARS-CoV-2
- COVID-19
- Pityriasis rubra pilaris
- Dermatology
- Exanthema
- Urticaria
- Pruritus
- Eczema
- Erythema Multiforme
- Keratoderma, Palmoplantar
Author Biographies
, Laboratorio de inmunología y virología, dirección de investigación, Hospital Regional Lambayeque. Chiclayo, Perú.
https://orcid.org/0000-0003-1943-5613
, Laboratorio de microbiología, servicio de laboratorio clínico, Hospital Regional Docente Belén de Lambayeque. Perú.
https://orcid.org/0000-0002-6086-4658
, Servicio de infectología, Hospital Regional Lambayeque. Chiclayo, Perú.
https://orcid.org/0000-0002-8090-8224
, Universidad San Ignacio de Loyola, Lima, Perú, Peru
https://orcid.org/0000-0003-2992-9342
References
Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. The Lancet Neurology. 2020;19(9):767-83. https://doi.org/10.1016/S1474-4422(20)30221-0
Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic. Reviews in endocrine & metabolic disorders. 2020;21(4):495-507. https://doi.org/10.1007/s11154-020-09569-2
Pirzada A, Mokhtar AT, Moeller AD. COVID-19 and Myocarditis: What Do We Know So Far? CJC open. 2020;2(4):278-85. https://doi.org/10.1016/j.cjco.2020.05.005
Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. Jama. 2020;324(6):603-5. https://doi.org/10.1001/jama.2020.12603
Darlenski R, Tsankov N. COVID-19 pandemic and the skin: what should dermatologists know? Clinics in dermatology. 2020;38(6):785-7. https://doi.org/10.1016/j.clindermatol.2020.03.012
Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. Journal of the American Academy of Dermatology. 2020;82(5):e177. https://doi.org/10.1016/j.jaad.2020.03.036
Marzano AV, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini BM, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients. Journal of the American Academy of Dermatology. 2020;83(1):280-5. https://doi.org/10.1016/j.jaad.2020.04.044
Mancilla-Gudiel PM, Arenas R. Pitiriasis rubra pilar: una revisión. Dermatología Cosmética, Médica y Quirúrgica. 2020;18(1):53-61.
Palencia AB, Ramos TIV. Pitiriasis rubra pilaris: aspectos epidemiológicos y clínicos de 44 casos. Dermatología Revista Mexicana. 2008;52(4):153-9.
Jimenez-Cauhe J, Ortega-Quijano D, Carretero-Barrio I, Suarez-Valle A, Saceda-Corralo D, Moreno-Garcia Del Real C, et al. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clinical and experimental dermatology. 2020;45(7):892-5. https://doi.org/10.1111/ced.14281
Carvajal C, Acosta A, Álvarez M. Pitiriasis rubra pilaris atípica en pediatría. A propósito de un caso. Archivos de Pediatría del Uruguay. 2017;88(5):279-83.
Ferrándiz-Pulido C, Bartralot R, Bassas P, Bodet D, Repiso T, Aparicio G, et al. Pitiriasis rubra pilaris aguda postinfecciosa: una dermatosis mediada por superantígenos. Actas Dermo-Sifiliográficas. 2009;100(8):706-9.https://doi.org/10.1016/S0001-7310(09)72284-7
Roenneberg S, Biedermann T. Pityriasis rubra pilaris: algorithms for diagnosis and treatment. Journal of the European Academy of Dermatology and Venereology : JEADV. 2018;32(6):889-98. https://doi.org/10.1111/jdv.14761
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020;34(5):e212-e3. https://doi.org/10.1111/jdv.16387
Williams A, George A, Thomas EA, Koshy JM. Pityriasis rubra pilaris type 6: A case report in an AIDS patient. Indian journal of sexually transmitted diseases and AIDS. 2020;41(1):100-1. https://doi.org/10.4103/ijstd.IJSTD_120_15
Ertam I, Sezgin AO, Kazandi A, Dereli T, Unal I. A case of juvenile pityriasis rubra pilaris: could varicella be an aetiological agent? Clinical and experimental dermatology. 2009;34(8):e1012-3. https://doi.org/10.1111/j.1365-2230.2009.03678.x
Gül Ü. COVID-19 and dermatology. Turkish journal of medical sciences. 2020;50(8):1751-9. https://doi.org/10.3906/sag-2005-182
Gisondi P, S PI, Bordin C, Alaibac M, Girolomoni G, Naldi L. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020;34(11):2499-504. https://doi.org/10.1111/jdv.16774
Copyright (c) 2021 Universidad del Valle
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
